Decoding the regulatory programs governing glioblastoma plasticity
A new multiomic atlas maps glioblastoma cell states, revealing regulatory programs that drive tumor plasticity.
8 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 8 separate news trends connected to Glioblastoma, spanning June 25, 2026 through November 4, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 65 article observations and 63 source signals, led by Health coverage. Use it to compare how individual events emerged, spread and changed over time.
A new multiomic atlas maps glioblastoma cell states, revealing regulatory programs that drive tumor plasticity.
Cancer drug's target mechanism may be different than scientists believed.
Phase 2b data for MimiVax’s SurVaxM vaccine reveals mixed signals in glioblastoma patients, sparking cautious optimism.
New research spots a calcium-linked weak point in glioblastoma, raising hopes for better therapies.
Eight studies published on August 21, 2026, suggest new hope for patients with brain tumors and another deadly cancer
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
New GPNMB CAR-T cell therapy shows potential to treat aggressive glioblastoma by targeting both tumors and their immune cell accomplices.
Researchers have identified a sex-specific immune pathway that drives aggressive brain cancer growth in females.